Annual EBIT
-$25.46 M
+$3.07 M+10.77%
31 December 2023
Summary:
Chemomab Therapeutics annual earnings before interest & taxes is currently -$25.46 million, with the most recent change of +$3.07 million (+10.77%) on 31 December 2023. During the last 3 years, it has fallen by -$19.49 million (-326.31%). CMMB annual EBIT is now -326.31% below its all-time high of -$5.95 million.CMMB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$3.71 M
+$58.00 K+1.54%
01 September 2024
Summary:
Chemomab Therapeutics quarterly earnings before interest & taxes is currently -$3.71 million, with the most recent change of +$58.00 thousand (+1.54%) on 01 September 2024. Over the past year, it has increased by +$657.00 thousand (+15.04%). CMMB quarterly EBIT is now -236.97% below its all-time high of -$1.10 million, reached on 30 June 2020.CMMB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$15.37 M
+$657.00 K+4.10%
01 September 2024
Summary:
Chemomab Therapeutics TTM earnings before interest & taxes is currently -$15.37 million, with the most recent change of +$657.00 thousand (+4.10%) on 01 September 2024. Over the past year, it has increased by +$14.88 million (+49.18%). CMMB TTM EBIT is now -802.23% below its all-time high of -$1.70 million, reached on 31 March 2020.CMMB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMMB EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.8% | +15.0% | +49.2% |
| 3 y3 years | -326.3% | -28.3% | -65.6% |
| 5 y5 years | - | - | - |
CMMB EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -326.3% | +10.8% | -28.3% | +59.0% | -65.6% | +55.0% |
| 5 y | 5 years | -326.3% | +10.8% | -237.0% | +59.0% | -802.2% | +55.0% |
| alltime | all time | -326.3% | +10.8% | -237.0% | +59.0% | -802.2% | +55.0% |
Chemomab Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.71 M(-1.5%) | -$15.37 M(-4.1%) |
| June 2024 | - | -$3.77 M(-6.9%) | -$16.03 M(-21.6%) |
| Mar 2024 | - | -$4.05 M(+5.2%) | -$20.46 M(-19.6%) |
| Dec 2023 | -$25.46 M(-10.8%) | -$3.85 M(-11.9%) | -$25.46 M(-15.8%) |
| Sept 2023 | - | -$4.37 M(-46.7%) | -$30.25 M(-11.5%) |
| June 2023 | - | -$8.20 M(-9.4%) | -$34.20 M(+6.0%) |
| Mar 2023 | - | -$9.05 M(+4.7%) | -$32.26 M(+13.1%) |
| Dec 2022 | -$28.53 M | -$8.64 M(+3.9%) | -$28.53 M(+14.5%) |
| Sept 2022 | - | -$8.32 M(+33.0%) | -$24.91 M(+27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$6.25 M(+17.6%) | -$19.49 M(+21.9%) |
| Mar 2022 | - | -$5.32 M(+5.9%) | -$15.99 M(+29.3%) |
| Dec 2021 | -$12.37 M(+107.1%) | -$5.02 M(+73.8%) | -$12.37 M(+33.2%) |
| Sept 2021 | - | -$2.89 M(+5.0%) | -$9.29 M(+21.9%) |
| June 2021 | - | -$2.75 M(+62.0%) | -$7.62 M(+27.7%) |
| Mar 2021 | - | -$1.70 M(-12.5%) | -$5.97 M(-0.1%) |
| Dec 2020 | -$5.97 M | -$1.94 M(+58.5%) | -$5.97 M(+48.2%) |
| Sept 2020 | - | -$1.23 M(+11.3%) | -$4.03 M(+43.7%) |
| June 2020 | - | -$1.10 M(-35.4%) | -$2.81 M(+64.6%) |
| Mar 2020 | - | -$1.70 M | -$1.70 M |
FAQ
- What is Chemomab Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual EBIT year-on-year change?
- What is Chemomab Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly EBIT year-on-year change?
- What is Chemomab Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Chemomab Therapeutics?
- What is Chemomab Therapeutics TTM EBIT year-on-year change?
What is Chemomab Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CMMB is -$25.46 M
What is the all time high annual EBIT for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual earnings before interest & taxes is -$5.95 M
What is Chemomab Therapeutics annual EBIT year-on-year change?
Over the past year, CMMB annual earnings before interest & taxes has changed by +$3.07 M (+10.77%)
What is Chemomab Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CMMB is -$3.71 M
What is the all time high quarterly EBIT for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly earnings before interest & taxes is -$1.10 M
What is Chemomab Therapeutics quarterly EBIT year-on-year change?
Over the past year, CMMB quarterly earnings before interest & taxes has changed by +$657.00 K (+15.04%)
What is Chemomab Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CMMB is -$15.37 M
What is the all time high TTM EBIT for Chemomab Therapeutics?
Chemomab Therapeutics all-time high TTM earnings before interest & taxes is -$1.70 M
What is Chemomab Therapeutics TTM EBIT year-on-year change?
Over the past year, CMMB TTM earnings before interest & taxes has changed by +$14.88 M (+49.18%)